Our work is to present the current status, and in the same time the need and benefit of establishment of Radiopharmacy practice in Eastern Africa using the perspective of Kenya and Ethiopia. The exact information on the status and size of Radiopharmacy units, regionally, is still not clearly documented, as well human resources, education, suitable training and local demand for the Radiopharmacy and Nuclear Medicine services. The Radiopharmacy Practice requires well-defined and controlled conditions to avoid the risk contamination with microbes, pyrogens and particulate matter as well as cross contamination with other radiopharmaceuticals. Corresponding to the expected improvement, the principles of Good Practices in all levels should be pla...
OBJECTIVE: While nuclear myocardial perfusion imaging (MPI) offers many benefits to patients with kn...
Purpose Low-and middle-income countries disproportionately comprise 65% of cancer deaths. Cancer car...
Radiopharmaceuticals account for more than 95% of the group of sterile pharmaceutical products and s...
Objectives: The article seeks to describe the current status of Radiopharmacy practice in Eastern A...
Recent activities of Boko Haram, a local extremist group in Nigeria, raise concerns about a nuclear ...
BACKGROUNDRadiopharmaceuticals are radiolabelled compounds designed to deliver diagnostic informatio...
IAEA AFRA TC in the last years is initiating in cooperation with its international partners and tech...
Purpose/Objective(s): There is a documented disparity in the distribution of radiotherapy (RT) servi...
Over the past 50 years, nuclear medicine and molecular imaging (NMMI) have grown tremendously across...
The sustainability of radiation biology (radiobiology) is under threat in South Africa because of u...
The Nuclear Medicine Global Initiative (NMGI) was formed in 2012 by 13 international organizations t...
Promoting nuclear medicine in developing countries trough IAEA coordintated research projec
In the advent of the coronavirus disease (COVID-19) pandemic, professional societies including the A...
The sustainability of radiation biology (radiobiology) is under threat in South Africa because of u...
Objective: While nuclear myocardial perfusion imaging (MPI) offers many benefits to patients with kn...
OBJECTIVE: While nuclear myocardial perfusion imaging (MPI) offers many benefits to patients with kn...
Purpose Low-and middle-income countries disproportionately comprise 65% of cancer deaths. Cancer car...
Radiopharmaceuticals account for more than 95% of the group of sterile pharmaceutical products and s...
Objectives: The article seeks to describe the current status of Radiopharmacy practice in Eastern A...
Recent activities of Boko Haram, a local extremist group in Nigeria, raise concerns about a nuclear ...
BACKGROUNDRadiopharmaceuticals are radiolabelled compounds designed to deliver diagnostic informatio...
IAEA AFRA TC in the last years is initiating in cooperation with its international partners and tech...
Purpose/Objective(s): There is a documented disparity in the distribution of radiotherapy (RT) servi...
Over the past 50 years, nuclear medicine and molecular imaging (NMMI) have grown tremendously across...
The sustainability of radiation biology (radiobiology) is under threat in South Africa because of u...
The Nuclear Medicine Global Initiative (NMGI) was formed in 2012 by 13 international organizations t...
Promoting nuclear medicine in developing countries trough IAEA coordintated research projec
In the advent of the coronavirus disease (COVID-19) pandemic, professional societies including the A...
The sustainability of radiation biology (radiobiology) is under threat in South Africa because of u...
Objective: While nuclear myocardial perfusion imaging (MPI) offers many benefits to patients with kn...
OBJECTIVE: While nuclear myocardial perfusion imaging (MPI) offers many benefits to patients with kn...
Purpose Low-and middle-income countries disproportionately comprise 65% of cancer deaths. Cancer car...
Radiopharmaceuticals account for more than 95% of the group of sterile pharmaceutical products and s...